Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.
Saved in:
| Title: | Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases. |
|---|---|
| Authors: | Jane EP; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Premkumar DR; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA., Rajasundaram D; Department of Pediatrics, University of Pittsburgh School of Medicine, PA, USA., Thambireddy S; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Reslink MC; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Agnihotri S; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA., Pollack IF; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA. |
| Source: | Molecular oncology [Mol Oncol] 2022 Jan; Vol. 16 (1), pp. 219-249. Date of Electronic Publication: 2021 Jun 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
